FNDX 📈 Schwab Fundamental U.S. - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US8085247711 • Large Value
FNDX: Technology, Finance, Consumer Goods, Healthcare, Energy
The Schwab Fundamental U.S. Large Company Index ETF, listed on the NYSE ARCA under the ticker FNDX, is designed to track the performance of large-cap companies in the US market, with a focus on fundamental analysis. Typically, the fund allocates at least 90% of its net assets to stocks that are part of its underlying index, which is constructed based on the fundamental overall company scores of US companies within the RAFI Global Equity Investable Universe. This approach allows for a diversified portfolio that reflects the financial health and stability of large companies in the US.
By investing in the FNDX ETF, investors gain exposure to a broad range of large-cap US companies, selected based on their fundamental strengths, such as revenue, dividends, and other financial metrics. The fund's underlying index is part of the RAFI (Research Affiliates Fundamental Index) series, which uses a rules-based approach to select and weight companies based on their fundamental characteristics, rather than market capitalization. This methodology aims to provide a more accurate representation of a company's true economic size and importance, rather than simply its market value.
As a US-domiciled ETF, FNDX is subject to US regulatory requirements and is listed on the NYSE ARCA, providing investors with easy access to the fund. With its ISIN code of US8085247711, the fund is also easily identifiable and accessible to international investors. The Schwab Fundamental U.S. Large Company Index ETF is classified as a large value ETF, indicating its focus on large-cap companies with strong fundamental profiles, which may appeal to investors seeking a value-oriented investment strategy.
In terms of its investment strategy, the FNDX ETF is designed to provide long-term capital appreciation by tracking the performance of its underlying index. The fund's portfolio is regularly rebalanced to ensure that it remains aligned with the index, and to maintain an optimal mix of large-cap US companies. By investing in the FNDX ETF, investors can gain diversified exposure to the US large-cap market, with a focus on companies that have demonstrated strong fundamental performance, which may help to reduce risk and increase potential long-term returns.
Additional Sources for FNDX ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FNDX ETF Overview
Market Cap in USD | 18,073m |
Category | Large Value |
TER | 0.25% |
IPO / Inception | 2013-08-15 |
FNDX ETF Ratings
Growth 5y | 92.5% |
Fundamental | - |
Dividend | 58.6% |
Rel. Strength Industry | 23.6 |
Analysts | - |
Fair Price Momentum | 25.33 USD |
Fair Price DCF | - |
FNDX Dividends
Dividend Yield 12m | 2.07% |
Yield on Cost 5y | 4.41% |
Annual Growth 5y | 10.81% |
Payout Consistency | 90.8% |
FNDX Growth Ratios
Growth Correlation 3m | 57.7% |
Growth Correlation 12m | 97% |
Growth Correlation 5y | 95.2% |
CAGR 5y | 16.26% |
CAGR/Mean DD 5y | 3.78 |
Sharpe Ratio 12m | 1.27 |
Alpha | -5.54 |
Beta | 0.97 |
Volatility | 22.07% |
Current Volume | 2361.7k |
Average Volume 20d | 1879.6k |
As of December 22, 2024, the stock is trading at USD 23.73 with a total of 2,361,700 shares traded.
Over the past week, the price has changed by -2.83%, over one month by -2.37%, over three months by +0.70% and over the past year by +21.26%.
Yes. Based on ValueRay Analyses, Schwab Fundamental U.S. (NYSE ARCA:FNDX) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 92.51 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FNDX as of December 2024 is 25.33. This means that FNDX is currently overvalued and has a potential downside of 6.74%.
Schwab Fundamental U.S. has no consensus analysts rating.
According to ValueRays Forecast Model, FNDX Schwab Fundamental U.S. will be worth about 28.1 in December 2025. The stock is currently trading at 23.73. This means that the stock has a potential upside of +18.54%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 28.1 | 18.5% |